Table 4. Characteristics of in silico predicted multi-epitope peptides.
| Protein | Peptide name | Synthetic multi-epitope sequence | AA* number | MW** (g/mol) | Peptide-binding HLA-I supertype concatenation |
|---|---|---|---|---|---|
| H2B | H2BI | KARYMSMSHRTMKSMSHRTMKIKAINAQMSMMERICTEAA | 40 | 4917.00 | HLA-A01, HLA-A02, HLA-A01/A03, HLA-A03, HLA-B08, HLA-B27, HLA-B44, HLA-B58, HLA-B62 |
| PSA | PSAI.3 | KTPEQRTNTLTVELGKKWIG | 19 | 2538.10 | HLA-B07, HLA-B08, HLA-B27 |
| PSAI.4 | KTLPEMPVGVPEMPAGVDY | 18 | 2268.83 | HLA-A01, HLA-A02, HLA-A01/A24, HLA-B08, HLA-B44, HLA-B62 | |
| PSAI.5 | KARGREGYFLARGARGREGYEGYFVTDEK | 28 | 3579.13 | HLA-A01, HLA-A02, HLA-A01/A03, HLA-A03, HLA-B27, HLA-B44, HLA-B58, HLA-B62 | |
| LmlRAB | RABI.2 | KARYRFAQGEHDIRLPENAFVIARYTQGSSKAGF | 34 | 4123.82 | HLA-A01, HLA-A02, HLA-A24, HLA-B27, HLA-B62 |
| RABI.3 | KARYMPHVDQSSIARYASFRSTEAIRYSSIMVVANK | 36 | 4373.20 | HLA-A01, HLA-A01/A03, HLA-A03, HLA-B07, HLA-B27 |
*AA: Amino acid
**MW: Molecular weight (g/mol) obtained by mass-spectrometry
Letters in bold (K, KARY, ARY, RY, TV) represent spacers added to the multi-epitope sequence.
Underlined glycine (G) replaces a cysteine C